EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antenatal melatonin for cardiovascular deficits in fetal growth restriction

Charmaine R Rock iD, Tegan A White iD, Beth R Piscopo, Amy E Sutherland iD, Yen Pham, Connor Karozis, Fiona L Cousins iD, Emily J Camm iD, Suzanne L Miller iD, Beth J Allison iD

The Journal of Physiology · 2026

DOI: 10.1113/jp288750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, 2026. Verfasst von Charmaine R Rock und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia. Hauptthemen laut MEDLINE: Melatonin, Fetal Growth Retardation, Antioxidants, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Government | DHAC | National Health and Medical Research Council (NHMRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fetal growth restriction (FGR) increases the risk of cardiovascular disease. FGR is linked to placental insufficiency and fetal hypoxemia, leading to oxidative stress and inflammation, which collectively influence the developmental programming of cardiovascular disease. This study assessed whether melatonin (MLT), a potent antioxidant and anti‐inflammatory agent, could prevent cardiovascular deficits associated with FGR. Placental insufficiency was induced in ewes at 89 days of gestational age (dGA, term 148 dGA). Ewes were randomly allocated to control, FGR or FGR+MLT ( i.v. , 15 mg day −1 , from 95 dGA to birth) groups. Lambs were delivered preterm at 136 dGA and assessed as newborn (24 h) and 4‐week‐old lambs. Vascular function was determined in femoral arteries using in vitro wire myography and vascular morphology as assessed in carotid and femoral arteries. Newborn FGR lambs were ∼30% smaller than control lambs with an increased brain‐to‐body weight ratio, indicative of brain sparing. Femoral endothelial function declined between ∼24 h after birth and 4 weeks in FGR lambs. By contrast, femoral arteries from newborn FGR+MLT lambs displayed transient endothelial dysfunction that improved by 4 weeks. However, these arteries showed elevated levels of oxidative stress and inflammation. Despite improving endothelial function, melatonin also disrupted the brain‐sparing response in FGR lambs. Furthermore, by 4 weeks of age, melatonin treatment led to heightened oxidative stress and inflammatory markers in the peripheral vasculature, suggesting a potential trade‐off between vascular benefits and systemic maladaptation. These findings highlight the complexity of melatonin's effects on the cardiovascular system and underscore the need for careful evaluation of its long‐term safety and efficacy before clinical translation. image Key points Fetal growth restriction (FGR) significantly increases the lifelong risk of cardiovascular disease, and there are currently no targeted treatments to mitigate these risks. This study follows growth‐restricted lambs from birth to 4 weeks of age (comparable to a 1‐year‐old human in terms of cardiovascular function) to characterise how FGR affects vascular development over time. FGR lambs exhibited progressive endothelial dysfunction in the femoral artery, but antenatal melatonin treatment restored endothelial function long‐term despite the presence of vascular oxidative stress and inflammation. The brain‐sparing response is a key adaptive mechanism for fetal survival, yet melatonin appears to dampen this response, highlighting the need for further investigation into its broader physiological effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninFetal Growth RetardationAntioxidantsCardiovascular DiseasesAnimalsFemaleSheepPregnancyOxidative StressFemoral ArteryEndothelium, VascularPlacental InsufficiencyAnimals, Newborn

Stichwörter der Autor:innen

brain sparingcardiovascularfetal growth restrictionmelatonin

Substanzen

MelatoninAntioxidants

Autor:innen und Institutionen

  • The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia.
  • Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia.

ORCID-Profile: Charmaine R Rock, Tegan A White, Amy E Sutherland, Fiona L Cousins, Emily J Camm, Suzanne L Miller, Beth J Allison

Förderung

  • Federal Government | DHAC | National Health and Medical Research Council (NHMRC)

Zitieren

APA

Rock, C. R., White, T. A., Piscopo, B. R., Sutherland, A. E., Pham, Y., Karozis, C., Cousins, F. L., Camm, E. J., Miller, S. L., & Allison, B. J. (2026). Antenatal melatonin for cardiovascular deficits in fetal growth restriction. The Journal of Physiology. https://doi.org/10.1113/jp288750

Vancouver

Rock CR, White TA, Piscopo BR, Sutherland AE, Pham Y, Karozis C, et al. Antenatal melatonin for cardiovascular deficits in fetal growth restriction. The Journal of Physiology. 2026. doi:10.1113/jp288750

BibTeX
@article{Rock2026,
  author = {Rock, Charmaine R and White, Tegan A and Piscopo, Beth R and Sutherland, Amy E and Pham, Yen and Karozis, Connor and Cousins, Fiona L and Camm, Emily J and Miller, Suzanne L and Allison, Beth J},
  title = {Antenatal melatonin for cardiovascular deficits in fetal growth restriction},
  journal = {The Journal of Physiology},
  year = {2026},
  doi = {10.1113/jp288750}
}
Kostenlos starten →